Same as you - I have been holding for 10+ years. I bought this for the promise PBT2 was showing in the Phase1 and going into the IMAGINE trial.
I still think that penalty for a poorly setup trial turned out to be too high with FDA dragging the company for years on the REACH2HD trial.
I don't know of any other MPAC which has showed more promise than PBT2 and I am not aware of any other approach to treat/prevent Alzheimers which has shown better results than addressing Aβ accumulation.
PBT434 is a blip in comparison to what I think PBT2 still has the potential to deliverer. It is a $3 stock if that comes thru!
What will happen on Nasdaq tonight?, page-263
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.454K | 484.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 73 | 107950070 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 271679 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |